APA (7th ed.) Citation

EL, D., EM, M., D, L., 3rd, S. A., RM, Y., JR, I., . . . SEM, H. (2019). TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib. Cancer research, 79(2), 360. https://doi.org/10.1158/0008-5472.CAN-18-0781

Chicago Style (17th ed.) Citation

EL, Dadashian, et al. "TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib." Cancer Research 79, no. 2 (2019): 360. https://doi.org/10.1158/0008-5472.CAN-18-0781.

MLA (9th ed.) Citation

EL, Dadashian, et al. "TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib." Cancer Research, vol. 79, no. 2, 2019, p. 360, https://doi.org/10.1158/0008-5472.CAN-18-0781.

Warning: These citations may not always be 100% accurate.